updat forecast estim dec
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research dec
estim dec
price data dec
rate updat dec
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
continu capit enviabl posit
exclus license cross shield brand state
would argu cross shield brand
recogniz trust franchis health insur
industri largest cross shield oper
claim second posit medic membership
behind posit particularli impress
limit geograph reach compar
share dive deep licens state claim averag
membership share around high local market share
remain particularli valuabl health insur industri sinc
medic care provid typic oper limit geograph
area make local market share relev
substanti local nation market share aim
deepen influenc provid client front
specif provid front use deep local
market share align incent value-bas
risk-shar relationship appear significantli
industri averag believ align like payer
provid could help rein healthcar cost trend
benefit client end user alik client front
launch ingeniorx pharmaci benefit manag
platform help provid holist view patient
health could lead better cost control manag
health condit aim roll servic exist
client expand reach cross shield
system particular
strateg initi like seek acceler
growth long run specif manag target
annual revenu growth adjust
earn per share core busi outlook remain
beyond near-term growth opportunitiei associ
transit express script pbm contract intern
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest privat health insur organ
nationwid provid medic benefit roughli million medic
member compani offer employ individu government-sponsor
coverag plan differ peer uniqu posit
largest singl provid cross shield brand coverag
oper license cross shield associ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rais fair valu estim
per share previous cash flow gener
sinc last updat higher free cash flow estim
next five year fair valu estim impli
time multipl expect earn
current assumpt appear roughli line
manag outlook around billion revenu
per share earn
assum top line rise adjust
earn per share grow compound annual
top line assum medic membership
grow around time-frame howev
expect membership growth come
fulli insur busi particularli govern busi
continu expand amplifi effect
revenu growth on-going mix shift fulli insur
membership expect medic cost trend
midsingl digit expect revenu per member grow
compound annual also
firm emerg pharmaci benefit manag
integr offer boost compani
bottom line expect slight oper margin
improv wring
effici increas scale howev would
note gross margin like pressur
primarili grow government-bas busi
also expect firm use share repurchas help boost
adjust earn per share growth total expect ep
grow compound annual
appear roughli line manag
long-term ep growth guidanc expect
free cash flow grow similarli earn around
compound annual billion
billion
discount assumpt weight averag
cost capit around
flow intermedi term posit effect
ingeniorx pbm migrat could off-set potenti
bull-cas scenario result fair valu
estim per share assum overal medic
enrol grow annual help better
medicar advantag medicaid growth along
stronger growth commerci segment assum
revenu growth per member rise mildli base-cas
scenario compound annual next
five year reflect mid-single-digit cost trend
price product higher penetr ancillari
product pbm offer scenario
firm oper margin rise nearli
base case also firm earn per
share free cash flow grow
compound annual five-year period end
scenario stock valu around
bear-cas scenario valu around
per share scenario assum public option
introduc current healthcar system
steal signific share employer-bas insur
roll specif assum lose
individu local group busi current rate
howev think firm abl retain lost
busi medicar advantag medicaid-bas
manag care plan similar profit exist
govern busi scenario estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
flow explicit indirect forecast period
earn narrow moat rate us
fundament anchor
top-tier scale-rel
advantag health insur strategi center
emphas strength state
licens cross shield brand name
oper posit state
measur medic membership state anthem
provid insur one everi three peopl
give scale-rel cost advantag network effect
market advantag help anthem
gener excess return base-cas scenario
assum return invest capit includ goodwil rise
low doubl digit recent year mid-teen
next five year well capit cost
scenario consid larg status-quo environ
still expect consist produc excess
return next year even public option
steal signific share employer-bas plan
introduc healthcar system support
narrow moat rate well
view inform analysi potenti chang
 healthcar system poll suggest half
 popul support medicar
scenario admittedli medicar scenario
 insur place insur market
oper could jeopardi howev
believ scenario repres low probabl
less risk within forecast period would
requir signific shift current feder govern
posit senat new presid left
wing democrat parti republican voter remain
significantli oppos plan next
year view scenario provid medic
pharmaceut benefit employ even
revenu could rise similar rate base
case next five year around compound
annual growth deceler outer year
forecast low singl digit versu midsingl
digit base case also oper margin contract
roughli membership mix shift influenc
on-going profit even includ share repurchas
scenario assum earn per share free cash
flow grow respect
compound annual basi five year end
specif expect free cash flow reach
billion versu billion base case
grow slowli thereaft explicit forecast
period scenario stock valu around
view like even dire
scenario bear-cas scenario possibl
exampl medicar scenario elimin
insur industri could jeopard
oper extrem scenario investor
know half enterpris valu
base-cas scenario relat valu firm cash
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
govern entiti medicar advantag
medicaid manag care plan much like
extrem medicar scenario privat
insur industri longer exist poll ad public
option current healthcar system support
roughli three quarter potenti voter strong
support even republican like
scenario suspect place privat health
insur relat pharmaci benefit manag like
 healthcar system rel long
period time
potenti polici chang consid
continu see two primari moat sourc -- cost advantag
network effect -- top-tier insur compani like
cost advantag relat primarili scale
local market oper
membership posit state oper
cross shield licens state
provid insur one everi three peopl
give signific scale-rel cost advantag sort
local scale advantag allow much greater negoti
leverag versu healthcar supplier particularli
servic provid smaller insur market
leverag servic provid allow
offer significantli lower price averag
 health insur even top-tier narrow moat peer
local scale advantag signific enough
think insur oper benefit network
effect exampl commun anthem
alreadi substanti market share abl offer lower
price product benefit per member exist
potenti client peer offer compel
enough employ attract anthem
insur plan commun local servic
provid hospit physician group
incent join offer lower price anthem
insur network gain access larg membership
roll local market share rise negoti
leverag healthcar supplier also rise
creat virtuou cycl attract even
client provid insur network
believ network effect strong
value-bas payment arrang provid
significantli higher across major line busi
averag insur align incent
lead better cost control end user overal
think dynam creat barrier entri new
competitor local market hard compil
attract price provid network without signific
membership share caregiv patient popul
assign anthem stabl moat trend view
sourc underpin econom moat
healthcar industri larg stabl asid distort
roic relat tax reform-rel effect
post remark consist return
invest capit low doubl digit sinc period
character signific chang
healthcar industri next five year view
scenario firm underli cost advantag
network effect materi erod substanti strengthen
unlik howev would note
perspect continu see room improv
econom profit near term exit
unfavor contract express script recent
acquir roll pharmaci benefit
manag platform ingeniorx end
compani expect drop roughli million annual
profit bottom line mere base insourc
pbm function exist member boost
earn power basi point
perspect even extern custom flock
new servic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
despit posit expect chang profit
otherwis roughli stabl view oper environ
remain lookout potenti regulatori chang
could usher neg moat trend industri player
eventu specif healthcar system
continu put signific financi pressur mani
citizen think medic insur pharmaci
benefit manag remain key target regul
look improv healthcar system long
run howev next five year expect
regul focu larg increas access
rather elimin privat insur industri
altogeth like scenario believ
underli sourc determin moat health
insur industri -- cost advantag network effect --
larg remain stabl exampl assum public
option introduc current healthcar system
earliest view possibl assum
public option steal signific share
non-govern insur roll possibl anthem
could lose exist non-govern busi
current rate specif bear-cas scenario
assum individu local group
smaller employ busi migrat current rate
public option think would abl
retain much busi anthem-sponsor plan
given on-going local scale advantag would expect
margin busi declin toward lower
margin govern busi scenario
estim margin contract would roughli eras
pbm-relat gain note long run
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
continu use scale-rel advantag
benefit client remain intrigu
firm on-going effort align incent
caregiv includ creation high perform
oth resolut firm long-stand contract
disput express script creation
ingeniorx platform support materi save
client higher profit
boost growth cross-sel
omanag aim high core earn growth
long run
ohealthcar reform like recur topic
throughout upcom elect cycl
could pose real fundament threat especi
extrem medicar requir gain traction
oth insur pbm industri like remain
larg target regul aim reduc
healthcar cost burden societi even make
elect larg unscath
oth bulk insur membership growth
come year stem
headwind insur profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
end septemb firm owe billion
debt debt/capit ratio debt/adjust
ebitda firm profit look set
rise end transit
pbm function expect de-lever
substanti long run fact aim oper
debt/capit slightli higher current
leverag also manag target capit alloc
follow next five year flexibl
deploy previou five year
buyback dividend chang given
capit deploy prioriti think compani
acquisit complimentari busi
activ may even boost leverag target directli
substanti transact exampl
will boost leverag well target
debt/capit attempt purchas howev
regul block merger anti-trust
concern current fight pay
billion termin fee specifi merger
agreement parti su
damag relat fail combin rule
possibl near futur believ
suffici resourc pay potenti termin
fee court rule must end
septemb held billion cash
balanc sheet typic hold billion
fund sourc billion revolv credit
facil billion commerci paper program
meet potenti outflow
flow intermedi term posit effect
ingeniorx pbm migrat could off-set potenti
regulatori chang given on-going regulatori threat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
think stock may constrain least
 elect cycl dire scenario would
medicar scenario elimin privat
insur industri threaten oper
view scenario probabl low point
creat signific event risk peer
even left wing democrat parti win white
hous view chang margin includ public
option like ad medicar advantag exchang
expand medicaid much like
medicar scenario elimin privat insur
especi democrat win fillibuster-proof
major posit senat insur like
play key role moder scenario could
even benefit expans servic provid
public option mere expand access insur rather
caus signific shift insur sourc
uncertainti may surround stock clariti
around path forward healthcar system
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
capit research manag compani
fidel manag research compani
share
fund
share
fund
give manag team standard
particularli impress board decis
bring gail boudreaux ceo late boudreaux
bring wealth industri experi prior
role aetna bcb
illinoi ceo
insur busi contenti
year includ public contract disput
express script fail acquisit think
reinvigor execut team focus futur
remain posit step forward boudreaux
alreadi made signific impact firm oper
earn growth trajectori rel short time
role distinct focu recaptur lost share firm
commerci market along collabor stanc
toward fellow plan sponsor defin part
strategi well
board put togeth compens scheme
manag think appropri see
area could improv time annual bonu
target tie perform oper profit
bonu indic qualiti servic
excel bonu long-term incent program
mix option restrict stock vest ratabl
cumul adjust incom oper revenu
view measur cumul incom revenu target
function similar annual bonu goal focus
oper profit would encourag board
consid ad return metric return invest
capit free cash flow gener mix
measur
firm three-year stagger board elect structur
mandat part licens agreement
bcbsa commend board signal prefer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
annual elect requir bcbsa
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
anthem turn strong rais outlook share
narrow-moat turn strong third-quart result
manag rais bottom-lin outlook full
year new expect slightli current
estim expect slight adjust like
chang fair valu estim especi given
manag cautiou initi view share close
discount fair valu estim oct
report strong quarterli revenu growth
billion surpass consensu expect
billion perform help solid
membership growth overal particular strength
medicar advantag growth commerci risk
growth revenu per member rose includ price
track firm roughli cost trend expand
servic per member new ingeniorx pharmaci
integr benefit manag increas
revenu forecast billion billion
previous higher expect premium
also control cost well particularli sg
line increas adjust earn per share year
year quarter consensu
strong result compani increas
earn outlook least
growth slightli estim year
note chang relat primarili
sg expens project basi point
lower expect percentag sale lower
share count million million
million million previous recent acceler
share repurchas may adjust near-term
forecast adjust probabl lead
substanti chang fair valu estim
increas may even off-set manag initi core
earn outlook low end
long-term project appear slightli
outlook manag includ risk
valuat attract across board aug
took detail look managed-car industri
came away confid posit outlook space
manag care remain attract industri
allow format sizabl econom moat
protect strong return capit almost everi corner
sector compani built advantag busi
model around monthli premium fee gener
recur revenu consolid past decad
allow competit remain ration despit
attract qualiti group trade modest discount
broader market reflect investor concern
futur healthcar polici regul unit
headlin domin variou democrat
parti polici propos medicar
would overhaul healthcar industri addit
manag care wrestl propos regulatori action
put forward trump administr so-
call rebat rule think medicar
function similar polici unlik next decad
administr abandon rebat rule earlier
year mark win industri valuat space
compress result heighten concern
market particip regard action think
investor long-term invest horizon stand
benefit own moatworthi firm favor
price integr servic offer unitedhealth
group make favorit among
five firm cover current trade discount
dcf-deriv fair valu estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
uncertainti like persist
gener elect cycl think group averag
valuat level roughli time earn emb
sizable-enough margin safeti warrant posit
detail analysi industri
assess potenti polici implic pleas see
risk manag creat opportun
moatworthi firm sizabl discount
character weak launch
pbm track ahead expect jul
narrow-moat post second-quart result
larg track full-year estim dont anticip
substanti chang fair valu estim
updat model view share slightli
under-valued today mid-single-digit sell-off
firm report strong revenu growth surpass
consensu expect help better-than-anticip
medicar advantag
commerci risk segment held well compar
enrol loss seen first half medicar
advantag firm seen membership growth roughli
year date far outstrip market growth
trend close period consolid medic
enrol growth continu track expect
manag bump outlook risk book
member full year
top line continu perform well felt
mani cost pressur report peer
last week notabl firm saw
increas medic loss ratio
post ratio basi point wors
project manag call inadequ rate
environ within hand medicaid state
primari driver weak year date bump
midpoint guidanc roughli basi point
impli moder rate increas
metric second half year rel
despit pressur firm roll pharmaci
benefit manag ingeniorx seem track ahead
plan pbm drive bulk increas
full-year ep guidanc addit firm sign
cross idaho ingeniorx first extern pharmaci
custom expect third-parti pbm sale
materi next sever year land earli
contract provid support valu aim
bring marketplac
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
